NCT07262567 2025-12-03
Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer
Genfleet Therapeutics (Shanghai) Inc.
Phase 3 Not yet recruiting
Genfleet Therapeutics (Shanghai) Inc.
Sanofi
Peking University Cancer Hospital & Institute
Fudan University
Xinjiang Medical University
Sun Yat-sen University